# The Efficacy of 10-day or 14-day Course of Bismuth-containing Quadruple Therapy:A Randomized Clinical Trial

> **NCT05586113** · PHASE4 · UNKNOWN · sponsor: **Shandong University** · enrollment: 398 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** 10-day Tegoprazan bismuth-containing quadruple therapy

## Key facts

- **NCT ID:** NCT05586113
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-06
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 398 (ESTIMATED)
- **Last updated:** 2023-02-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05586113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05586113, "The Efficacy of 10-day or 14-day Course of Bismuth-containing Quadruple Therapy:A Randomized Clinical Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05586113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*